DELVINO, PAOLO
 Distribuzione geografica
Continente #
AS - Asia 3.661
NA - Nord America 1.847
EU - Europa 1.340
SA - Sud America 702
AF - Africa 89
OC - Oceania 19
Totale 7.658
Nazione #
US - Stati Uniti d'America 1.750
SG - Singapore 991
CN - Cina 717
VN - Vietnam 683
BR - Brasile 530
HK - Hong Kong 492
IT - Italia 428
RU - Federazione Russa 343
JP - Giappone 172
FR - Francia 120
KR - Corea 119
IN - India 102
GB - Regno Unito 77
AR - Argentina 71
DE - Germania 71
BD - Bangladesh 67
ES - Italia 58
TR - Turchia 54
ID - Indonesia 51
IQ - Iraq 44
SE - Svezia 39
MX - Messico 37
CA - Canada 36
NL - Olanda 27
PK - Pakistan 27
VE - Venezuela 25
ZA - Sudafrica 25
CO - Colombia 24
SA - Arabia Saudita 24
FI - Finlandia 23
UA - Ucraina 23
CH - Svizzera 21
EC - Ecuador 20
PL - Polonia 18
UZ - Uzbekistan 18
IE - Irlanda 17
AU - Australia 16
AT - Austria 14
MA - Marocco 13
CL - Cile 12
KE - Kenya 12
PH - Filippine 12
TW - Taiwan 11
BE - Belgio 10
EG - Egitto 10
TH - Thailandia 10
LB - Libano 9
AZ - Azerbaigian 8
AL - Albania 7
TN - Tunisia 7
CR - Costa Rica 6
ET - Etiopia 6
HR - Croazia 6
IL - Israele 6
MY - Malesia 6
PE - Perù 6
RO - Romania 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
JM - Giamaica 5
NP - Nepal 5
PA - Panama 5
PY - Paraguay 5
SY - Repubblica araba siriana 5
BY - Bielorussia 4
DZ - Algeria 4
GR - Grecia 4
JO - Giordania 4
LT - Lituania 4
LV - Lettonia 4
QA - Qatar 4
BO - Bolivia 3
KZ - Kazakistan 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
PT - Portogallo 3
SN - Senegal 3
AO - Angola 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
GE - Georgia 2
NO - Norvegia 2
OM - Oman 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BW - Botswana 1
DM - Dominica 1
GH - Ghana 1
HN - Honduras 1
IM - Isola di Man 1
IR - Iran 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
Totale 7.650
Città #
Singapore 544
Hong Kong 482
San Jose 339
Ashburn 276
Hefei 243
Ho Chi Minh City 210
Hanoi 196
Seoul 114
Milan 100
Beijing 88
The Dalles 80
Los Angeles 72
Chicago 69
Dallas 63
Tokyo 55
Ann Arbor 54
Lauterbourg 50
Moscow 44
São Paulo 44
New York 41
Buffalo 38
Santa Clara 38
Turin 35
Shanghai 34
Jakarta 32
Rome 24
Da Nang 23
Madrid 21
Rio de Janeiro 20
Biên Hòa 19
Paris 19
Council Bluffs 18
Frankfurt am Main 18
Haiphong 18
Dublin 17
Osaka 17
Quận Bình Thạnh 17
Tashkent 17
Baghdad 16
Florence 16
Guangzhou 15
Belo Horizonte 14
Orem 14
Chennai 13
Hải Dương 13
Istanbul 13
London 13
Riyadh 13
Amsterdam 12
Ankara 12
Buenos Aires 12
Mexico City 12
Montreal 12
Stockholm 12
Caracas 11
Johannesburg 11
Kent 11
Mumbai 11
Quito 11
Ryōke 11
Carate Brianza 10
Lappeenranta 10
Nairobi 10
Nuremberg 10
Seattle 10
Toronto 10
Denver 9
Dhaka 9
Munich 9
Salt Lake City 9
Salvador 9
Vienna 9
Atlanta 8
Bogotá 8
Brasília 8
Ha Long 8
Helsinki 8
Houston 8
Manaus 8
Manchester 8
Recife 8
Ribeirão Preto 8
Vũng Tàu 8
Warsaw 8
Baku 7
Bologna 7
Boston 7
Brescia 7
Brooklyn 7
Brussels 7
Jeddah 7
Matsuyama 7
Ninh Bình 7
Taiyuan 7
Wilmington 7
Bern 6
Can Tho 6
Chandler 6
Charlotte 6
Curitiba 6
Totale 4.184
Nome #
Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group 564
Characteristics and outcome of ANCA-associated vasculitides induced by anti-thyroid drugs: a multicentre retrospective case-control study 308
Systemic vasculitis: one year in review 2024 286
Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome) 284
Frailty and cardiovascular safety of JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a real-world comparative study of drug effects and patient profiles 235
Approccio innovativo agli unmet needs nella gestione a lungo termine dei pazienti affetti da vasculite ANCA-associata 219
Novel insights into the management of rheumatoid arthritis: one year in review 2024 205
Systemic vasculitis: one year in review 2022 198
Humoral and T-cell immune response following three doses of SARS-CoV-2 mRNA vaccine in giant cell arteritis: analysis of a prospective cohort 194
Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis 174
Factors influencing patient-reported outcomes in ANCA-associated vasculitis: correlates of the Patient Global Assessment 170
Systemic vasculitis: one year in review 2025 161
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study 154
Clinical picture, outcomes and predictors of relapse in eosinophilia-associated coronary vasospasm: data from a European multicentric study 148
Nivolumab and ipilimumab-induced eosinophilic granulomatosis with polangiitis in a patient treated with dupilumab 143
Massive abdominal haemorrhage due to sequential omental vasculitis and ruptured aneurysms in a patient with granulomatosis with polyangiitis 139
Remission and Low Disease Activity in Granulomatosis With Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage Accrual 135
Impact of mepolizumab on patient-reported outcomes in eosinophilic granulomatosis with polyangiitis by using the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire 132
Ultrasound halo sign as a potential monitoring tool for patients with giant cell arteritis: A prospective analysis 129
Asma, EGPA, HES: elementi di diagnostica differenziale 127
The role of extra-corporeal membrane oxygenation (ECMO) in the treatment of diffuse alveolar haemorrhage secondary to ANCA-associated vasculitis: report of two cases and review of the literature 126
Clinical Image: Extensive subcutaneous calcinosis cutis with fistulization in refractory dermatomyositis 125
Impact of Anti-Citrullinated Protein Antibodies on Progressive Systemic Bone Mineral Density Loss in Patients With Early Rheumatoid Arthritis After Two Years of Treat-to-Target 124
A 28-Year-Old Man with Stridor and Dyspnea 124
Azathioprine vs methotrexate in eosinophilic granulomatosis with polyangiitis: a monocentric retrospective study 124
Set the scene: Key points dell’Inquadramento e diagnosi differenziale dell’EGPA 118
Novel Therapies for ANCA-associated Vasculitis 116
Quale approccio diagnostico al paziente con iper-eosinofilia? 115
Asma ed ipereosinofilia 113
Severe immunoglobulin A vasculitis with refractory gastrointestinal involvement in an adult patient successfully treated with plasma exchange 112
One year in review 2020: vasculitis 106
Fast-Track Ultrasound Clinic for the Diagnosis of Giant Cell Arteritis Changes the Prognosis of the Disease but Not the Risk of Future Relapse 106
Long-term maintenance of remission with spacing of rituximab infusions based on the individualised patient risk profile in ANCA-associated vasculitis: a pilot study 105
Systemic vasculitis: one year in review 2023 104
A New Era for the Early and Non‐Invasive Diagnosis of Giant Cell Arteritis: The Use of Fast‐Track Ultrasound in Clinical Practice 103
Update on Treatment of Antisynthetase Syndrome: A Brief Review 102
Successful treatment with baricitinib in a patient with refractory cutaneous dermatomyositis 101
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies 99
The role of trimethoprim/sulfametoxazole in reducing relapses and risk of infections in ANCA-associated vasculitis: a meta-analysis 97
Cytomegalovirus colitis unmasking human immunodeficiency virus infection as a cause of IgA vasculitis 96
Immunosuppressive treatments selectively affect the humoral and cellular response to SARS-CoV-2 in vaccinated patients with vasculitis 95
Safety of BNT162b2 mRNA COVID-19 vaccine in a cohort of elderly, immunocompromised patients with systemic vasculitis 94
Cobalt hip prosthesis intoxication mimicking an autoimmune disease 89
Prevalence of Whipple's disease in north-western Italy 89
ANCA-Associated Vasculitides and Polyarteritis Nodosa - EULAR on-line course on Rheumatic Diseases 88
Lumbar spondylolisthesis associated with systemic sclerosis-related spinal calcinosis: an unusual clinical case 87
Impact of immunosuppressive treatment on the immunogenicity of mRNA COVID-19 vaccine in vulnerable patients with giant cell arteritis 86
One year in review 2021: Systemic vasculitis 84
Correspondence on 'EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs' 84
Is it really infective endocarditis? Distinguishing systemic vasculitis from its mimics 83
An unusual reno-pulmonary complication in the course of systemic sclerosis 81
Impact of delayed diagnoses at the time of COVID-19: Increased rate of preventable bilateral blindness in giant cell arteritis 81
Cobalt hip prosthesis intoxication mimicking an autoimmune disease 80
Striking abdominal aortic stenosis revealing Takayasu's arteritis 78
Clinical outcomes of subglottic stenosis in granulomatosis with polyangiitis: results of an international multicentre observational study 75
Asma e poliposi nasale: quando preoccuparsi? 72
Erratum: Successful treatment with baricitinib in a patient with refractory cutaneous dermatomyositis (Rheumatology (2020) 59 (e125-e127) DOI: 10.1093/rheumatology/keaa184) 72
Overlapping forms of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis: Insights from a European multicenter study 66
Early detection and risk stratification in autoimmune-related interstitial lung disease: a state-of-the-art review 51
Beyond Oral Anticoagulants Two case reports of Biopsy-Proven Heparin-Induced Anticoagulant-Related Nephropathy 22
Systemic vasculitis: one year in review 2026 21
Totale 7.899
Categoria #
all - tutte 24.002
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.002


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 0 0 0 0 13 10
2021/202273 12 9 7 10 12 8 6 1 1 3 1 3
2022/202337 4 12 4 2 1 5 1 2 6 0 0 0
2023/2024334 0 1 1 0 7 9 9 0 131 11 50 115
2024/20252.822 154 265 68 112 167 97 194 83 219 334 298 831
2025/20264.601 610 481 432 559 339 235 661 276 417 455 136 0
Totale 7.899